Oulu university hospital,department of neurology
Oulu, Northern Finland, 90029, Finland
NCT Number: NCT01861275
Obstructive sleep apnoea is a risk factor for ischaemic stroke. study hypothesis: In prospective study the investigators want to know how many ischaemic stroke patients have sleep apnoea and does thrombolysis play a role in severity of osa in six months follow up.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Oulu, Northern Finland, 90029, Finland
In prospective study the investigators include all over 18 years old patients who came to emergency room for ischaemic stroke. Exclusion criteria is not able to co-operate or need for intensive care unit.The investigators shall take 100 control patients who have ischaemic stroke and no thrombolysis and 100 study patients who will have thrombolysis. The investigators do sleep registration during hospital staying within 2 days after patients have felt ill.Follow-up registration will be done after 6 months at home.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Nasal CPAP treatment for obstructive sleep apnoea
Time frame: from six months to twenty four months
in prospective study outcome measure is severity of osa in 6months follow-up
University of Oulu
Other
Obstructive Sleep Apnea as a Risk Factor for Ischaemic Stroke , a Prospective Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04071860
Apnea, Dyssomnias
Cambridge, Cambridgeshire, United Kingdom
View Trial DetailsNCT03638895
Apnea, Body Weight
Liverpool, United Kingdom
View Trial DetailsNCT02939586
Apnea, Chronic Disease
Newcastle, New South Wales, Australia
View Trial DetailsNCT00708786
Apnea, Dyssomnias
Brest, France
View Trial Details